Protagenic Therapeutics earnings were -$8.9M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest PTIX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$869.5k, down 82.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PTIX reported annual earnings of -$5.5M, with 10.5% growth.
Protagenic Therapeutics Earnings Reports & History FAQ
What were Protagenic Therapeutics's earnings last quarter?
Protagenic Therapeutics (NASDAQ: PTIX) reported Q3 2025 earnings per share (EPS) of -$0.47, up 69.48% year over year. Total PTIX earnings for the quarter were -$869.50 thousand. In the same quarter last year, Protagenic Therapeutics's earnings per share (EPS) was -$1.54.
Is Protagenic Therapeutics profitable or losing money?
As of the last Protagenic Therapeutics earnings report, Protagenic Therapeutics is currently losing money. Protagenic Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$8.92 million, a 107.11% increase year over year.
What was PTIX's earnings growth in the past year?
As of Protagenic Therapeutics's earnings date in Q4 2025, Protagenic Therapeutics's earnings has grown year over year. PTIX earnings in the past year totalled -$8.92 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.